D-0327-2021 Class II Terminated
FDA drug recall D-0327-2021 was initiated by Cosette Pharmaceuticals, Inc. on Mar 25, 2021 and is designated Class II. Reason for recall: CGMP Deviaitons The recall status is terminated (terminated Jul 17, 2023). Affected quantity: a) 30 mL: 7724 b) 60 mL: 8064 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 14, 2021
- Initiation Date
- Mar 25, 2021
- Termination Date
- Jul 17, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 30 mL: 7724 b) 60 mL: 8064 bottles
Product description
Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080
Reason for recall
CGMP Deviaitons
Distribution pattern
Nationwide in the US
Code information
a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0327-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026